Intravenous Immunoglobulin for Unverricht-Lundborg Disease.
Clinical trial NCT03351569 · UNKNOWN
Trial details
- NCT number
- NCT03351569
- Sponsor
- Azienda Socio Sanitaria Territoriale di Mantova
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-09
- Primary completion
- 2016-12-06
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.